Search

everythinglearnresearchcommunity

for

Search:↓

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

Prolactin may be important for skin growth and immune function.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

New compounds may soon be tested to treat excessive hair growth in women.

Using neurohormones to control keratin can lead to new skin disease treatments.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Cantú syndrome may be linked to pituitary adenomas.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Skin health and diseases are closely linked to metabolic processes.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Acne is a chronic skin condition not caused by poor hygiene or diet, and it requires long-term treatment and patient education.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.